Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikita Malhotra

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 27, 2013
A review of patient-reported outcomes for children and adolescents with obesityBani Ahuja, Anne F Klassen, Randi Satz, et al.
Plos One|December 21, 2018
Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trialsMohammed A M Farooqi, Nikita Malhotra, Som D Mukherjee, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 1, 2021
The association of PRECISE-DAPT score with ischaemic outcomes in patients taking dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisCole R Clifford, Rene Boudreau, Sarah Visintini, et al.
International Journal of Cardiology|April 19, 2016
A pharmacodynamic analysis for the co-administration of inducers of CYP3A with ticagrelor: A cautionary tale in managing patients with acute coronary syndromesAli Pourdjabbar, Benjamin Hibbert, Aun-Yeong Chong, et al.
Clinical Cardiology|January 11, 2016
Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding ComplicationsAngel Fu, Kuljit Singh, Joseph Abunassar, et al.
Journal of Cardiology|June 21, 2022
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trialGraeme Prosperi-Porta, Pouya Motazedian, Pietro Di Santo, et al.
International Journal of Cardiology|July 8, 2015
A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic windowNikita Malhotra, Joseph Abunassar, George A Wells, et al.
European Heart Journal. Acute Cardiovascular Care|January 10, 2018
Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y<sub>12</sub> receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgeryJuan J Russo, Tyler E James, Marc Ruel, et al.
The Canadian Journal of Cardiology|September 23, 2022
Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized TrialRichard G Jung, Pietro Di Santo, Rebecca Mathew, et al.
The Canadian Journal of Cardiology|February 8, 2025
Evaluating Volume and Resource Needs for Implementing an ST-Elevation Myocardial Infarction Shock ProtocolRene Boudreau, Michel Le May, Nikita Malhotra, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 27, 2013
A review of patient-reported outcomes for children and adolescents with obesityBani Ahuja, Anne F Klassen, Randi Satz, et al.
Plos One|December 21, 2018
Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trialsMohammed A M Farooqi, Nikita Malhotra, Som D Mukherjee, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 1, 2021
The association of PRECISE-DAPT score with ischaemic outcomes in patients taking dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisCole R Clifford, Rene Boudreau, Sarah Visintini, et al.
International Journal of Cardiology|April 19, 2016
A pharmacodynamic analysis for the co-administration of inducers of CYP3A with ticagrelor: A cautionary tale in managing patients with acute coronary syndromesAli Pourdjabbar, Benjamin Hibbert, Aun-Yeong Chong, et al.
Clinical Cardiology|January 11, 2016
Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding ComplicationsAngel Fu, Kuljit Singh, Joseph Abunassar, et al.
Journal of Cardiology|June 21, 2022
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trialGraeme Prosperi-Porta, Pouya Motazedian, Pietro Di Santo, et al.
International Journal of Cardiology|July 8, 2015
A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic windowNikita Malhotra, Joseph Abunassar, George A Wells, et al.
European Heart Journal. Acute Cardiovascular Care|January 10, 2018
Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y<sub>12</sub> receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgeryJuan J Russo, Tyler E James, Marc Ruel, et al.
The Canadian Journal of Cardiology|September 23, 2022
Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized TrialRichard G Jung, Pietro Di Santo, Rebecca Mathew, et al.
The Canadian Journal of Cardiology|February 8, 2025
Evaluating Volume and Resource Needs for Implementing an ST-Elevation Myocardial Infarction Shock ProtocolRene Boudreau, Michel Le May, Nikita Malhotra, et al.
Pageof 1